CHE NYSE Week ended 31 Jul 2026

Weekly Investor Report

Chemed Corp · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 532.2 USD
4.1% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 21.6% above the Trend Line and sits at 89.6% of its 52-week range. The latest completed week returned 4.1%, after a 8.7% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bearish with 47/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: earnings are due in 3d.

Setup score 59 out of 100
Latest Close 532.2 USD 31 Jul 2026
1W Return 4.1% latest completed week
4W Return 8.7% short-term follow-through
12W Return 25.6% quarterly tape
Trend Breadth 11.5% 6 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Next-week expectancy is negative at 44.68% based on similar historical setup states.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.1% Latest completed week; four-week move 8.7%. Indicator stack 24/70 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 44.68% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bearish 47/100 conviction; expected move 4.9%. News sentiment 55/100 58 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 21.6% above the Trend Line and sits at 89.6% of its 52-week range. The latest completed week returned 4.1%, after a 8.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5812-week average 0.27

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership5/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.58Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 8.7% over four weeks, 25.6% over 12 weeks, and 28.1% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W4.1%
4W8.7%
12W25.6%
26W24.9%
52W28.1%
Active trend streak5 weeks
Active weeks in one year6
Trend breadth11.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.07Latest activity-pressure read.
Pressure change15.6%Four-week change in activity pressure.
Leadership11.57Latest relative-leadership reading.
RS change362.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength24/100Blend of value, momentum, and quality. Underlying universe rank 77; rank 1 is best.
Value15/100Relative valuation strength. Underlying universe rank 86; rank 1 is best.
Quality91/100Profitability and accounting quality. Underlying universe rank 10; rank 1 is best.
Momentum31/100Medium-term price momentum. Underlying universe rank 70; rank 1 is best.
Growth5/100Revenue and earnings growth. Underlying universe rank 96; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework69/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
26.1x
Price divided by trailing earnings.
Price / sales
2.7x
Market value relative to trailing revenue.
EV / EBITDA
16.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
7.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
30.3%
Gross profit retained from each unit of revenue.
Operating margin
13.9%
Operating profit retained from revenue.
Free-cash-flow margin
20.1%
Free cash flow generated from revenue.
Return on invested capital
24.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
2.1%
Latest one-year revenue growth.
EPS growth
-15.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
22.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.5%
Cash dividends relative to market value.
Buyback yield
8.6%
Net share repurchases relative to market value.
Shareholder yield
9.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

CHE shows bearish options pressure with a 47/100 conviction score, put-call volume ratio of n/a, expected move of 4.9%, and Sharemaestro trend signal active.

Conviction47/100
Expected move4.9%
Put/call volume
Pressure-89
Speculation16
Volatility37
Trend agreement11
Open options detail
Insider activity7 / 5

7 acquisitions and 5 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 58 relevant articles.

19 positive · 34 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move4.9%Nearest-chain priced movement where available.
52-week drawdown-3.5%Distance below the 52-week high.
13-week volatility3.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+9.5%Week of 24 Apr.
Worst week-13.6%Week of 27 Feb.
Latest week+4.1%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains9
Flat weeks0
Modest losses6
Sharp losses3
Recent vol3.2%13-week weekly-return volatility.
Base vol3.7%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape53/100

Trend, activity pressure, participation, and risk combine to a 53/100 tape read.

 Indicator analysis58/100

Latest 12-week confirmation: trend 5/12, activity pressure 12/12, relative leadership 5/12.

Activity pressure 0.58; No reversal markers Next-Week ExpectancyNegative 44.68%

Next-week expectancy is negative with a 44.68% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors40/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 6; Small Cap Core rank 75 SVQF69/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 312.5 of 1011 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options29/100

CHE shows bearish options pressure with a 47/100 conviction score, put-call volume ratio of n/a, expected move of 4.9%, and Sharemaestro trend signal active.

Bearish · Put-side pressure · Expected move 4.9% Sentiment55/100

Weighted news tone is neutral across 58 relevant articles.

Chemed (CHE) Deepens Buybacks as Activist Pressure Mounts – What Does This Say About Strategy? Insiders7 / 5

7 acquisitions and 5 disposals in the latest 180-day insider tape.

 Earnings3d

Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026532.2 USD4.1%437.6 USD517.7 USD1.0711.571.0MOn
24 Jul 2026511.1 USD0.2%434.0 USD517.6 USD1.008.44836.3KOn
17 Jul 2026510.0 USD4.4%431.3 USD517.6 USD1.017.40741.0KOn
10 Jul 2026488.6 USD-0.2%428.8 USD517.9 USD1.021.19738.8KOn
3 Jul 2026489.7 USD5.7%426.8 USD518.2 USD0.922.50702.9KOn
26 Jun 2026463.3 USD6.2%424.5 USD518.4 USD0.92-1.231.1MOff
19 Jun 2026436.3 USD4.0%423.6 USD518.9 USD0.65-9.951.3MOff
12 Jun 2026419.3 USD-5.0%423.8 USD519.5 USD0.44-13.53992.8KOff
5 Jun 2026441.6 USD3.6%424.3 USD520.3 USD0.38-9.381.1MOff
29 May 2026426.4 USD-2.8%424.0 USD520.8 USD0.17-15.54800.4KOff
22 May 2026438.8 USD1.1%424.1 USD521.5 USD0.23-12.88965.3KOff
15 May 2026433.9 USD2.4%424.0 USD522.1 USD0.22-14.061.2MOff
8 May 2026423.7 USD0.5%424.1 USD522.8 USD-0.07-16.831.0MOff
1 May 2026421.6 USD0.2%424.3 USD523.5 USD-0.28-16.331.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.